Dosing concepts
How semaglutide dosing is typically structured
How clinicians generally think about semaglutide titration — starting low, escalating slowly, and what to discuss with your prescriber. Not a dosing instruction.
6 min read · Updated 2026-05-24
Peptide GPS publishes educational information, not medical advice. We don't sell, prescribe, or recommend specific medications, dosages, or providers. Always discuss any therapy with a licensed clinician.
Why dosing is gradual
Semaglutide is almost always started at a low introductory dose and increased step-wise over weeks or months.
The goal of this titration is to reduce gastrointestinal side effects — nausea, reflux, and constipation — which are the most common reason people stop the drug.
Faster escalation does not produce faster weight loss in trials; it mostly produces more side effects.
The general shape of a titration
A starter dose intended only to let the body adjust, not to drive results.
Several escalation steps, typically every four weeks, each higher than the last.
A maintenance dose — the level a person stays on long-term once tolerability and response are established.
Why this article does not list numbers
Specific milligram values depend on the brand (Ozempic vs Wegovy vs Rybelsus), the indication being treated, the prescriber''s judgment, and the individual''s response and tolerability.
Treating numbers off an article as a protocol is exactly the failure mode this site exists to prevent.
What to discuss with a clinician
How long they plan to stay at each step before escalating.
What side effects warrant slowing down or pausing escalation.
What the target maintenance dose is, and what determines whether you stop escalating earlier.
What the plan is if a dose is missed for one week or more.
Key takeaways
- Semaglutide is titrated slowly to manage side effects, not to delay results.
- The pattern is starter dose → stepped escalation → maintenance.
- Specific numbers depend on brand, indication, and the individual — they belong in a clinician conversation, not an article.
Get the weekly brief
One plain-English email per week on GLP-1s, peptides, and the regulation around them.